These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37119665)

  • 1. Corrigendum to "Discovery of a potent, selective and cell active inhibitor of m6A demethylase ALKBH5" [Eur. J. Med. Chem. 238 (2022) 114446].
    Fang Z; Mu B; Liu Y; Guo N; Xiong L; Guo Y; Xia A; Zhang R; Zhang H; Yao R; Fan Y; Li L; Yang S; Xiang R
    Eur J Med Chem; 2023 Jul; 255():115368. PubMed ID: 37119665
    [No Abstract]   [Full Text] [Related]  

  • 2. The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKKε/TBK1/IRF3 pathway in head and neck squamous cell carcinoma.
    Jin S; Li M; Chang H; Wang R; Zhang Z; Zhang J; He Y; Ma H
    Mol Cancer; 2022 Apr; 21(1):97. PubMed ID: 35395767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a potent, selective and cell active inhibitor of m
    Fang Z; Mu B; Liu Y; Guo N; Xiong L; Guo Y; Xia A; Zhang R; Zhang H; Yao R; Fan Y; Li L; Yang S; Xiang R
    Eur J Med Chem; 2022 Aug; 238():114446. PubMed ID: 35597008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.
    Guo X; Li K; Jiang W; Hu Y; Xiao W; Huang Y; Feng Y; Pan Q; Wan R
    Mol Cancer; 2020 May; 19(1):91. PubMed ID: 32429928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of m6A demethylase (ALKBH5, FTO) genetic polymorphism and expression levels on the development of pulmonary tuberculosis.
    Zhang TP; Li R; Wang LJ; Li HM
    Front Cell Infect Microbiol; 2022; 12():1074380. PubMed ID: 36619747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ALKBH5 Inhibited Cell Proliferation and Sensitized Bladder Cancer Cells to Cisplatin by m6A-CK2α-Mediated Glycolysis.
    Yu H; Yang X; Tang J; Si S; Zhou Z; Lu J; Han J; Yuan B; Wu Q; Lu Q; Yang H
    Mol Ther Nucleic Acids; 2021 Mar; 23():27-41. PubMed ID: 33376625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demethylase ALKBH5 suppresses invasion of gastric cancer via PKMYT1 m6A modification.
    Hu Y; Gong C; Li Z; Liu J; Chen Y; Huang Y; Luo Q; Wang S; Hou Y; Yang S; Xiao Y
    Mol Cancer; 2022 Feb; 21(1):34. PubMed ID: 35114989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ALKBH5 regulates STAT3 activity to affect the proliferation and tumorigenicity of osteosarcoma via an m6A-YTHDF2-dependent manner.
    Yang Z; Cai Z; Yang C; Luo Z; Bao X
    EBioMedicine; 2022 Jun; 80():104019. PubMed ID: 35490460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The biological function of m6A demethylase ALKBH5 and its role in human disease.
    Wang J; Wang J; Gu Q; Ma Y; Yang Y; Zhu J; Zhang Q
    Cancer Cell Int; 2020; 20():347. PubMed ID: 32742194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corrigendum to "Discovery of new azoles with potent activity against Candida spp. and Candida albicans biofilms through virtual screening" [Eur. J. Med. Chem. 179 (2019) 634-648].
    Sari S; Kart D; Öztürk N; Kaynak FB; Gencel M; Taşkor G; Karakurt A; Saraç S; Eşsiz Ş; Dalkara S
    Eur J Med Chem; 2020 Mar; 190():112130. PubMed ID: 32074493
    [No Abstract]   [Full Text] [Related]  

  • 11. ALKBH5 inhibits the SIRT3/ACC1 axis to regulate fatty acid metabolism via an m6A-IGF2BP1-dependent manner in cervical squamous cell carcinoma.
    Zhen L; Pan W
    Clin Exp Pharmacol Physiol; 2023 May; 50(5):380-392. PubMed ID: 36705046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of m6A-factors METTL3, ALKBH5, and YTHDC1 alters HPV16 mRNA splicing.
    Cui X; Nilsson K; Kajitani N; Schwartz S
    Virus Genes; 2022 Apr; 58(2):98-112. PubMed ID: 35190939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of m6A mRNA modification by DNA hypermethylated ALKBH5 aggravates the oncological behavior of KRAS mutation/LKB1 loss lung cancer.
    Zhang D; Ning J; Okon I; Zheng X; Satyanarayana G; Song P; Xu S; Zou MH
    Cell Death Dis; 2021 May; 12(6):518. PubMed ID: 34016959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corrigendum to "Discovery of orally active anticancer candidate CFI-400945 derived from biologically promising spirooxindoles: Success and challenges" [Eur. J. Med. Chem. 95 (2015) 35-40].
    Yu B; Yu Z; Qi PP; Yu DQ; Liu HM
    Eur J Med Chem; 2016 Nov; 124():248. PubMed ID: 27592393
    [No Abstract]   [Full Text] [Related]  

  • 15. RNA demethylase ALKBH5 promotes ovarian carcinogenesis in a simulated tumour microenvironment through stimulating NF-κB pathway.
    Jiang Y; Wan Y; Gong M; Zhou S; Qiu J; Cheng W
    J Cell Mol Med; 2020 Jun; 24(11):6137-6148. PubMed ID: 32329191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALKBH5 prevents hepatocellular carcinoma progression by post-transcriptional inhibition of PAQR4 in an m6A dependent manner.
    Wang W; Huang Q; Liao Z; Zhang H; Liu Y; Liu F; Chen X; Zhang B; Chen Y; Zhu P
    Exp Hematol Oncol; 2023 Jan; 12(1):1. PubMed ID: 36609413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased
    Luo Q; Gao Y; Zhang L; Rao J; Guo Y; Huang Z; Li J
    Biomed Res Int; 2020; 2020():5735279. PubMed ID: 32884942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The N6-Methyladenosine Regulator
    Zhao Y; Sun J; Jin L
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. m
    Onalan E; Yakar B; Onalan EE; Karakulak K; Kaymaz T; Donder E
    J Coll Physicians Surg Pak; 2022 Sep; 32(9):1143-1148. PubMed ID: 36089710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ALKBH5-Mediated m6A Demethylation of GLUT4 mRNA Promotes Glycolysis and Resistance to HER2-Targeted Therapy in Breast Cancer.
    Liu H; Lyu H; Jiang G; Chen D; Ruan S; Liu S; Zhou L; Yang M; Zeng S; He Z; Wang H; Li H; Zheng G; Liu B
    Cancer Res; 2022 Nov; 82(21):3974-3986. PubMed ID: 36069931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.